Tag: Cancer: Lung
Many Pulmonologists Under-, Over-Screen With LDCT
Under-screeners more likely to cite potential harms as influential factors, less influenced by evidence
Novel Prediagnostic Biomarker ID’d for Non-Small-Cell Lung CA
Diacetylspermine identified as serum biomarker; has additive performance with pro-surfactant protein B
Nonsmokers Account for Rising Proportion of Lung Cancer Cases
U.S. and U.K. studies highlight the increasing prevalence of lung cancer in never-smokers
Limited Resection Generally Not Equivalent in Stage IA NSCLC
Only segmentectomy equivalent to lobectomy for older patients with adenocarcinoma
Accuracy, Timing of Pre-Op Lung CA Evaluation Can Be Improved
Most patients have pre-op CT scans; 88 percent have no invasive preoperative staging
Telomere Length May Help Predict Lung Cancer Risk
No significant association seen between telomere length and other types of cancer
![Iressa (gefitinib) has been approved by the U.S. Food and Drug Administration to treat patients with metastatic non-small-cell lung cancer with a specific genetic mutation (epidermal growth factor receptor [EGFR]). A just-approved companion diagnostic test can identify patients who could benefit from this new use.](https://www.ehealth-news.com/wp-content/uploads/2016/01/fdalogo-6-180x84.jpg "FDA Approves Iressa for EGFR+ Metastatic Lung Cancer")
FDA Approves Iressa for EGFR+ Metastatic Lung Cancer
New companion diagnostic kit can identify candidates
Yearly CT May Adequately Monitor Non-Solid Lung Nodules
Surgery found 100 percent curative, regardless of the time to treatment
Lung Disease Under Radar for Many Long-Term Smokers
Many considered disease-free based on their spirometry results
Surgery Deemed Fitting for Some Stage IIIB NSCLC Patients
Longer overall survival in patients undergoing surgical resection, compared to chemo-radiation only
